This inventor holds 88 USPTO granted patents and 21 published patent applications, plus 3 CIPO patents and 12 EPO patents, primarily in Pharmaceutical Chemistry (CPC class C07D-). Top assignees: Elan Pharmaceuticals, Inc., Wyeth, Cortexyme, Inc.. Active years: 2001-2025.
Inventors with similar research interests:
Location History:
- San Francisco, CA (US) (2001 - 2010)
- Burlingame, CA (US) (2006 - 2024)
Company Filing History:
49 out of 202 
24 out of 1,309 
9 out of 9 
Years Active: 2001-2025
Areas of Expertise:
Of course! Here is the article about inventor Andrei William Konradi:
Title: The Innovations of Andrei William Konradi
Introduction:
Andrei William Konradi, a talented inventor based in Burlingame, CA (US), has made significant contributions to the field of pharmaceuticals with his numerous patented inventions. With 83 patents to his name, Konradi is a pioneering figure in the realm of medical research and innovation.
Latest Patents:
Among his latest patented inventions are groundbreaking compounds aimed at treating cancers mediated by YAP/TAZ and fungal diseases. The first patent focuses on bicyclic compounds that target cancers influenced by the YAP/TAZ pathway, offering a promising avenue for therapeutic intervention. The second patent introduces pyridine derivatives with potent antifungal properties, presenting new possibilities for combating fungal diseases and infections.
Career Highlights:
Konradi's exceptional career includes notable stints at Elan Pharmaceuticals, Inc. and Wyeth, where he has honed his expertise in pharmaceutical research and development. His innovative approach to drug discovery has led to the creation of groundbreaking compounds that have the potential to revolutionize cancer and antifungal treatments.
Collaborations:
Throughout his career, Konradi has collaborated with accomplished professionals in the field of pharmaceuticals. Notable individuals such as Christopher Michael Semko and Michael A. Pleiss have worked alongside Konradi, contributing their expertise to the development of novel pharmaceutical compounds.
Conclusion:
In conclusion, Andrei William Konradi stands out as a prolific inventor in the realm of pharmaceuticals, with a remarkable track record of 83 patents to his name. His innovative compounds targeting cancers and fungal diseases showcase his dedication to advancing medical research and improving patient outcomes. Konradi's collaborations with esteemed colleagues further underscore his commitment to fostering innovation in the pharmaceutical industry.